Global Sepsis Diagnostics Market Report, Recent Trends, Growth Driving Factors, Challenges, Opportunities, Strategies, Recent Developments, Product Segments, and Growth Forecast 2019 – 2028
Sepsis Diagnostics: Overview
"The Sepsis Diagnostics Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031."
Sepsis is defined as the body's reaction to an infection, commonly caused by bacterial infection in the blood known as septicemia. A human body normally releases chemicals into bloodstream to fight the infectious disease, which often happens to be an important factor for diagnosing the disease.
Increasing prevalence of chronic infectious diseases such as sepsis is resulting in requirement of early diagnosis in order to protect or cure patients. Sepsis causes severe inflammation, resulting in prolonged hospitalization and can even cause death. To reduce the prevalence of sepsis in patients developing septicemia and the global burden of the disease, it is necessary to diagnose and treat sepsis. This is a major factor expected to drive global market growth over the next 10 years.
For instance, according to the World Health Organization, the rate at which ICU-acquired patients can get the infections is more than two to three times higher than in other hospital-wards, especially in developing countries. Infectious diseases include surgical-site wound infections and urinary tract infections that most often result in severe sepsis.
Increasing number of post-operative surgical infections can gradually lead to septic shock. These infections often arise due to improper or no sterilization of surgical instruments and surgical site. Increasing prevalence of various chronic diseases such as diabetes is leading to higher number of patients with hospital-acquired infections (HAI), and inclining number of footfalls at critical-care hospitals can result in cross contaminations and infections, which causes sepsis.
These are other major factors driving market growth to significant extent. For instance, according to a report published by the World Health Organization, nearly 7 among 100 patients are prone to develop HAI in developed economies. Additionally, in developing countries 10 out of 100 patients get affected by hospital-acquired infections, mainly due to under-developed healthcare infrastructure. The aforementioned facts indicate the higher demand and requirement for sepsis diagnosis globally.
Some other facts that are indicative of rising need for prevention and cure of sepsis:
- According to a report published by Global Sepsis Alliance (GSA), nearly 26 Mn people develop sepsis yearly, and approximately 8 Mn patients die globally because of sepsis.
- In addition, the US statistics show that over 1.6 Mn individuals are diagnosed with sepsis every year, which is projected to grow at the rate of 8% every year. Sepsis, as per the Global Sepsis Alliance, accounts for a higher number of deaths in the US, compared to the number of deaths caused by AIDS, breast cancer, and prostate cancer.
- Furthermore, in Germany, sepsis infectious disease is among the top three major causes of death. In accordance with this fact, between 2007 and 2013, incidence rate of sepsis in Germany increased by an average of 15 % a year and the number of cases reached 252,812 in 2013 from 110,653 in 2007.
However, prolonged hospitalizations and high cost of sepsis treatment are major factors that could restrain growth of the global sepsis diagnostics market to some extent.
Sepsis Diagnostics Market: Segment Analysis
Product Type Insights:
Among the product type segments, the blood culture media segment is expected to dominate in the target market, as blood culture is considered as the most preferred method by healthcare professionals and is comparatively cost-effective mode of testing.
Technology Type Insights:
Among the technology type segments, the microbiology segment is estimated to record the highest revenue contribution in the target market. Microbiology procedures allow quantitative detection and identification of microorganisms while diagnosing sepsis. Revenue from the molecular diagnostics segment is projected to expand significantly due to benefits such as reduced hospital stays leading to less expensive treatment costs.
Pathogen Type Insights:
Among the pathogen type segments, the bacterial sepsis segment is projected to witness the highest revenue growth in the target market over the 10-year forecast period. This is attributable to increasing prevalence of sepsis caused by bacterial infection.
Sepsis Diagnostics Market: Region Analysis
Currently, the North America market accounts for major revenue share in the global market and is projected to maintain its dominance over the 10-year forecast period. Key factors such as well-established healthcare infrastructure and early and higher adoption of technologically advanced products in countries in the North America market. The US market is estimated to record the highest revenue contribution in the North America sepsis diagnostics market. revenue from the Asia Pacific market is projected to expand at a lucrative CAGR in the target market, due to increasing number of patients suffering from sepsis infectious disease, and increasing investments by the government for development of healthcare infrastructure, growing number of diagnostic centers, and growing medical tourism industry.
Global Sepsis Diagnostics Market Segmentation:
Segmentation Based on Product Type:
- Assay Kits and Reagents
- Others (Software, Blood Culture Media, etc.)
Segmentation by Technology Type:
- Molecular Diagnostics
- Flow Cytometry
Segmentation by Pathogen Type:
- Bacterial Sepsis
- Gram-Positive Bacteria
- Gram-Negative Bacteria
- Fungal Sepsis
Segmentation by Testing Type:
- Laboratory Testing
- PoC Testing
Segmentation by Region:
- North America
- Latin America
- Asia Pacific
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Abbott Laboratories
- Becton, Dickinson and Company
- bioMérieux SA
- Hoffmann-LA Roche Ltd
- Beckman Coulter, Inc.
- Thermo Fisher Scientific, Inc.
- Cepheid Inc.
- Bruker Corporation
- Nanosphere, Inc.
- Immunexpress Inc.
- Luminex Corporation
- Response Biomedical Corp.
- T2 Biosystems, Inc.
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!